SC 13G: Alto Neuroscience, Inc.

Ticker: ANRO · Form: SC 13G · Filed: 2024-11-14T00:00:00.000Z

Sentiment: neutral

Topics: sc-13g

AI Summary

SC 13G filing by Alto Neuroscience, Inc..

Risk Assessment

Risk Level: low

From the Filing

0001193125-24-257978.txt : 20241114 0001193125-24-257978.hdr.sgml : 20241114 20241114070029 ACCESSION NUMBER: 0001193125-24-257978 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-94343 FILM NUMBER: 241457060 BUSINESS ADDRESS: STREET 1: 650 CASTRO STREET, SUITE 450 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 650 CASTRO STREET, SUITE 450 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Etkin Amit CENTRAL INDEX KEY: 0002007795 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: C/O ALTO NEUROSCIENCE, INC. STREET 2: 650 CASTRO STREET, SUITE 450 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 SC 13G 1 d873145dsc13g.htm SC 13G SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No.  )* Alto Neuroscience, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 02157Q109 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☐ Rule 13d-1(c) ☒ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 02157Q109 13G Page 2 of 5 Pages  1   NAME OF REPORTING PERSONS  I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)  Amit Etkin  2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*  (a) ☐  (b) ☐  3  SEC USE ONLY  4  CITIZENSHIP OR PLACE OF ORGANIZATION  United States NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH 5   SOLE VOTING POWER  1,461,130 1 6  SHARED VOTING POWER  0 7  SOLE DISPOSITIVE POWER  1,461,130 1 8  SHARED DISPOSITIVE POWER  0  9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  1,461,130 1 10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*  ☐ 11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  5.4% 2 12  TYPE OF REPORTING PERSON*  IN 1 Consists of: (i) 1,205,465 shares of the Issuers common stock and (ii) 255,665 shares of common stock issuable upon the exercise of stock options within 60 days of September 30, 2024. Does not include 34,711 shares of the Issuers common stock issuable upon the vesting of an outstanding restricted stock unit which vests in two equal installments on September 1, 2025 and March 1, 2026, subject to the Reporting Persons continuous service through such vesting date. 2 This percentage is calculated based upon 26,970,168 outstanding shares of the Issuers common s